News

Helios Fairfax Partners Welcomes New CFO Amid Changes

Helios Fairfax Partners Welcomes New CFO Amid Changes

Helios Fairfax Partners Announces Exciting Leadership Changes

Helios Fairfax Partners Corporation (TSX: HFPC.U), a prominent investment holding company, has initiated a significant change in its leadership structure. This decision aims to streamline operations and enhance financial reporting efficiency within the organization. Through this transition, the finance function will now be combined with that of its investment manager, Helios Investment Partners, under one leadership role. This strategic move is set to foster greater collaboration, resulting in improved efficiency and possible cost savings.

Embracing a New Chapter: Leadership Transition

Belinda Blades, who has been serving as the Chief Financial Officer, has announced her departure from the company to pursue new interests. Her last day will be at the end of May 2025, but she will assist in ensuring a smooth transition until the end of June 2025. Ms. Blades' leadership has been invaluable in setting a solid foundation for Helios Fairfax, and her contributions will be greatly appreciated as she embarks on her new endeavors.

Introducing Jennifer Lisbey as the New CFO

Steps are already being taken toward a seamless transition as Jennifer Lisbey has been appointed to take on the role of Chief Financial Officer following Ms. Blades' departure. Ms. Lisbey has an extensive background in finance and investments, coming from her role as Managing Director and Head of Fund Finance at Pantheon Ventures. Her experience managing a substantial portfolio, approximately $65 billion, has equipped her with the skills necessary to navigate this new role effectively.

Jennifer’s professional journey started at Deloitte LLP and she has held various senior finance positions within the Private Equity and Real Estate sectors. Notably, her work at Pantheon Ventures involved overseeing two listed investment trusts, which further highlights her qualifications for this new challenge. As a Chartered Accountant, she is well-equipped to handle the Strategic Financial leadership of Helios Fairfax Partners.

Company Leaders Express Enthusiasm

Tope Lawani and Babatunde Soyoye, Co-CEOs of Helios Fairfax, expressed their excitement in welcoming Jennifer to the team. They noted, "Her depth of financial and investment experience, along with her outstanding leadership skills, make her an invaluable addition to Helios Fairfax Partners. We are confident that she will play a significant role in executing our strategic direction and growth initiatives over the upcoming years." Their statements reflect a unified vision of continued progress and a strong commitment to the company's future success.

About Helios Fairfax Partners Corporation

Helios Fairfax Partners Corporation is dedicated to investing in public and private equity securities as well as debt instruments focused on the African market. The company is committed to long-term capital appreciation while also ensuring the preservation of capital. Through strategic investments, it aims to bolster businesses either operating within Africa or engaged with the African market, thereby enhancing economic growth and sustainability.

For further inquiries, Helios Fairfax encourages interested parties to reach out directly for more information regarding their operations or investment strategy.

Frequently Asked Questions

What prompted the leadership changes at Helios Fairfax Partners?

The changes are aimed at streamlining operations and enhancing financial reporting efficiencies within the organization.

Who is the new Chief Financial Officer of Helios Fairfax Partners?

Jennifer Lisbey has been appointed as the new CFO following the departure of Belinda Blades.

What experience does Jennifer Lisbey bring to the role?

Jennifer brings extensive experience in finance and investment management, previously working at Pantheon Ventures where she oversaw significant funds.

What contributions did Belinda Blades make during her time as CFO?

Belinda has played a crucial role in establishing a solid foundation for strategic growth and has been instrumental in the company's financial strength.

What is the investment focus of Helios Fairfax Partners Corporation?

The company primarily invests in public and private equity securities and debt instruments within Africa, aiming for long-term capital appreciation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 258

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 216

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 110

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 0

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading

Top 5 Most Recently Viewed Articles

Omni-Lite Industries Reports Impressive Fiscal Q3 Results

Updated Category News Views 143

Highlights from Omni-Lite's Third Quarter Fiscal 2025 Outstanding Financial Performance Omni-Lite Industries Canada Inc. (TSXV: OML) recently reported its financial results for the third quarter of fiscal 2025, demonstrating notable growth and resilience. With revenue reaching approximately US$4.0 million, Omni-Lite saw a remarkable year-over-year increase of 7.0%...

Continue Reading
Assessing the Impact of UK Fiscal Policy on Housing Market Trends

Updated Category News Views 200

Understanding the Current UK Housing Market Dynamics The U.K. housing market is currently facing a notable slowdown, primarily driven by tax-related uncertainties associated with fiscal policies. As potential buyers adopt a more cautious stance, residential property transactions have seen a decline. This trend poses immediate risks for sectors linked to housing, including...

Continue Reading
Radford Racing School Unveils New Exciting Driving Adventures

Updated Category News Views 226

Exciting New Driving Experiences at Radford Racing School Recently, Radford Racing School, known as a leader in performance driving education, announced its latest offerings that promise to thrill automotive enthusiasts of all ages and skill levels. With the introduction of six new driving experiences, there's now something for everyone at their legendary racetrack....

Continue Reading
AppLovin CEO Sells $21.5 Million in Shares Amid Growth Momentum

Updated Category News Views 137

AppLovin CEO's Notable Stock Sale Recently, AppLovin Corp (NASDAQ: APP) made headlines with a significant financial event: CEO and Chairperson Arash Adam Foroughi sold over $21.5 million worth of company stock. According to the latest SEC filing, this noteworthy transaction occurred over just two days, with share prices varying from $98.08 to $112.33 during that time....

Continue Reading
Olverembatinib's Breakthrough Status Enhances Leukemia Treatment Options

Updated Category News Views 396

Olverembatinib Gains Breakthrough Therapy Designation Ascentage Pharma, a prominent global biopharmaceutical company, is making significant strides in the treatment of serious medical conditions. With its latest achievement, olverembatinib has secured a Breakthrough Therapy Designation in China for its use alongside low-intensity chemotherapy in newly-diagnosed patients...

Continue Reading